Skip to the case study
All case studies
Contents
The results
The subject: Micron
The investor's dilemma
The algorithm
“The weekly paycheck”
“The patient buyer”
“The 2026 scoreboard”
Side by side
Why the results differ
The real lesson
A path forward
Book a demo
Case studies
MU
Case study: Arch Public for stocks
MU: a trillion-dollar run, a 41% drop in five weeks, and three recipes that paid in cash
The Market Wave Algorithm for Equities turns Micron’s swings into realized profit in three windows, beating buy and hold and DCA each time.
Micron: the AI memory maker that has more than tripled this year, never in a straight line.
MU
Stock
Market Wave Algorithm for Equities
Valued September 23, 2026
7 min read
Why this case study, and why now
Micron has more than tripled this year, and for anyone who held, every dollar of that gain is still on paper. This study asks whether a rule can do the selling instead, and turn Micron’s swings into cash as they happen.
Three windows, three recipes of the Market Wave Algorithm for Equities:
The weekly paycheck
Weekly chart, micro recipe, June 1 to September 18, 2026
Strategy
+44.2%
Buy and hold
+17.6%
DCA
+10.5%
The patient buyer
Four hour chart, buy-below recipe, June 1 to September 23, 2026
Strategy
+45.9%
Buy and hold
+3.3%
DCA
+12.5%
The 2026 scoreboard
Four hour chart, full-size recipe, January 1 to September 23, 2026
Strategy
+461.7%
Buy and hold
+247.1%
DCA
+100.3%
Every run starts from the same hypothetical $100,000 in cash and zero shares.
Backtested results. Past performance does not guarantee future results. For educational purposes only.
Micron, MU
Micron’s year in seven dates
Micron makes memory and storage chips for data centers, PCs, and phones, including the high-bandwidth memory that feeds AI processors. AI demand sold out its 2026 high-bandwidth memory and more than quadrupled its quarterly revenue in a year.
Record high, Jun 25
$1,255
Low, Jul 29
$739
Jan 2 Up more than 10% on the year’s first trading day, as Bernstein raises its target.
Mar 18 Quarterly revenue nearly triples, to $23.86 billion. The stock falls 15% in four days.
May 26 Micron becomes a trillion-dollar company.
Jun 4 to 5 A fifth of its value disappears in two sessions, to $864.
Jun 25 A record high of $1,255, the day after revenue more than quadrupled to $41.46 billion.
Jul 29 A low near $739, 41% below the peak, as the memory bear market deepens.
Sep 23 Near $1,080, a week before earnings on September 30.
Here is the catch that matters for this study: Micron paid holders on paper, then took back 41% of the peak in five weeks. Only gains already sold were safe.
The investor’s dilemma
Micron is a nerve test, and nerve is not a strategy.
41%
Taken back from the peak in five weeks
The paper gain trap
A January buyer had roughly quadrupled their money at the June 25 high. Five weeks later 41% of that peak value was gone, and none of the gain had been realized.
The too high freeze
Every entry looked like the top. Buyers who waited for a pullback got one on June 4 and 5, a fifth off in two days, hesitated, and watched a record three weeks later.
Narrative whiplash
On June 23 Micron fell 13.3% on a Korean regulator’s warning about memory ETFs. Two days later it hit a record on quadrupled revenue. Every headline explained the last move, never the next.
Dollar cost averaging deserves credit. It doubled this year without a timing decision. But it buys blind, never sells, and never realizes a dollar, so it rode the 41% drop with every share it had bought.
A rules-based algorithm restores what Micron takes away: a way to get paid while the stock swings.
Market Wave Algorithm for Equities
The algorithm
Ride confirmed moves
It enters when price meets a preset rule, and keeps adding while the move holds. It never needs a headline.
Exit on rules, not nerves
It sells a set share of the position at a profit target. It sold Micron into the June run.
Step aside in chop
Without a signal, it waits. The patient recipe held cash for eight weeks, through the peak and the drop.
Each recipe sets three levers: scope (0.5 micro to 20 macro), thresholds, and trade size.
The weekly paycheck, weekly chart
Scope 1
0.5 micro 20 macro
The weekly paycheck runs scope 1 and sells 83% of its shares per exit.
The patient buyer, four hour chart
Scope 7.5
0.5 micro 20 macro
The patient buyer runs scope 7.5 and only buys below the wave.
The 2026 scoreboard, four hour chart
Scope 10
0.5 micro 20 macro
The 2026 scoreboard runs scope 10 at full size.
Backtested results. Past performance does not guarantee future results. For educational purposes only.
Scenario one
“The weekly paycheck”
June 1 to September 18, 2026 · Weekly chart · Micro recipe, sells 83% of its shares on each exit
Strategy return
+44.2%
Buy and hold +17.6%, outperformance +26.6 percentage points
DCA +10.5%, outperformance +33.7 percentage points
Ending value
$144,231
Realized profit
$37,906
Unrealized profit
$6,325
Shares held
133 at $968.25 avg cost
Cash
$9,129
Bought the June 5 close after the two-day drop, sold into the run toward the record, and repeated the cycle through the summer’s drops and rebounds.
Open full-size chart
The number to read The number to read is $37,906 realized, 85.7% of the gain.
Backtested results on the weekly chart, valued at the September 18, 2026 weekly close. Past performance does not guarantee future results. For educational purposes only.
Scenario two
“The patient buyer”
June 1 to September 23, 2026 · Four hour chart · Buy-below recipe, scope 7.5
Strategy return
+45.9%
Buy and hold +3.3%, outperformance +42.6 percentage points
DCA +12.5%, outperformance +33.4 percentage points
Ending value
$145,932
Realized profit
$28,531
Unrealized profit
$17,401
Shares held
99 at $900.23 avg cost
Cash
$39,408
No trades from June 1 until the last days of July. First buys at the late July low, sales into the August rebound, rebuys in mid September, and a sale into this week’s rally.
Open full-size chart
The number to read The number to read is $39,408 in cash.
Backtested results on the four hour chart, valued September 23, 2026. Past performance does not guarantee future results. For educational purposes only.
Scenario three
“The 2026 scoreboard”
January 1 to September 23, 2026 · Four hour chart · Full-size recipe, scope 10
Strategy return
+461.7%
Buy and hold +247.1%, outperformance +214.6 percentage points
DCA +100.3%, outperformance +361.4 percentage points
Ending value
$561,731
Realized profit
$416,560
Unrealized profit
$45,171
Shares held
519 at $994.37 avg cost
Cash
$485
Buys on dips and sales into rallies all year, through the run to June, the July drop, and the rebound since.
Open full-size chart
The number to read The number to read is $416,560 realized: more than four times the starting capital, and 90.2% of the gain.
Backtested results on the four hour chart, valued September 23, 2026. Past performance does not guarantee future results. For educational purposes only.
Side by side
Read the realized row first. Buy and hold and DCA realized nothing in any window. Every dollar of their return is still on paper.
MU results by scenario
The weekly paycheck
The patient buyer
The 2026 scoreboard
Window
Jun 1 to Sep 18, 2026
Jun 1 to Sep 23, 2026
Jan 1 to Sep 23, 2026
Chart
Weekly
Four hour
Four hour
Recipe
Scope 1, 93% in, 83% out
Scope 7.5, buy below the wave
Scope 10, 100% in, 90% out
Strategy return
+44.2%
+45.9%
+461.7%
Buy and hold
+17.6%
+3.3%
+247.1%
Outperformance
+26.6 pts
+42.6 pts
+214.6 pts
DCA
+10.5%
+12.5%
+100.3%
Outperformance vs DCA
+33.7 pts
+33.4 pts
+361.4 pts
Ending value
$144,231
$145,932
$561,731
Realized profit
$37,906
$28,531
$416,560
Share of gain realized
85.7%
62.1%
90.2%
Shares held
133
99
519
Avg cost basis
$968.25
$900.23
$994.37
Cash
$9,129
$39,408
$485
All three start from a hypothetical $100,000 in cash and zero shares.
Backtested results. Weekly window valued at the September 18, 2026 weekly close, four hour windows valued September 23, 2026. Past performance does not guarantee future results. For educational purposes only.
Why the results differ
One algorithm, three questions.
Can a volatile stock pay you as it swings?
The weekly recipe sold most of its shares into each rally and bought back each drop, realizing $37,906 in one summer.
Can you skip the top without predicting it?
The patient recipe waited eight weeks for price to reach the wave, then bought the drop.
What did this year actually pay?
The 2026 recipe realized $416,560 on $100,000.
Buy and hold decides once and waits. DCA decides once and repeats.
The edge is not prediction. None of these recipes knew June 25 was the top.
Backtested results. Past performance does not guarantee future results. For educational purposes only.
The real lesson
01
Volatility can be income, if something sells
Micron swung double digits again and again this summer. Holding turned each swing into stress. Selling by rule turned them into $37,906 of realized profit.
02
Selling is the only way to keep a gain
Micron gave back 41% of its peak in five weeks, and holders kept none of the top. Every recipe here sold into strength by rule.
03
Cash is a position, not a missed trade
The patient recipe held cash for eight weeks, through the record and the 41% drop, then bought near the low. It still beat buy and hold by 42.6 percentage points.
The client decision is which job you want done: harvest every swing, wait for the big drop, or compound a year of profit-taking. The Market Wave Algorithm for Equities has a recipe for each.
Backtested results. Past performance does not guarantee future results. For educational purposes only.
A path forward
Arch Public runs the Market Wave Algorithm for Equities in your own account.
Zero custody. Full control.
Rules, not reactions.
What do you want your account doing the next time a stock drops 41% in five weeks?
Book a demo Or talk with the Concierge team
On paper, a January buy and holder is up
247.1%
The same $100,000 under the 2026 recipe is worth
$561,731
with $416,560 realized.
More case studies
META
Volatility Harvesting for Meta
Strategy return +217.8% in “The AI race accumulator”
Read the case study PLTR
Volatility Harvesting for Palantir
Strategy return +312% in “The gap buyer, finer wave”
Read the case study MRNA
MRNA: a pandemic boom, a 90% bust, and this month's spike
Strategy return +1,187% in “The round trip”
Read the case study
See every case study
Important disclosures
Arch Public is a software provider, not a registered investment adviser. Nothing in this case study is investment advice or a recommendation to buy or sell any security. All results are backtested using the Market Wave Algorithm for Equities on historical data and are hypothetical. Backtested performance has inherent limitations: it is prepared with the benefit of hindsight, does not reflect actual trading, and does not account for all fees, taxes, slippage, or market conditions. Past performance, backtested or otherwise, does not guarantee future results. Trading securities involves risk of loss, including loss of principal. Ticker history and price levels are drawn from public market data. For educational purposes only.
© 2026 Arch Public. All rights reserved. Published September 23, 2026.
Terms and conditions
Privacy policy
Cookies and trackers
Your privacy choices